JME Ventures
VC Fund
Madrid, Spain
JME Ventures is a VC fund in Madrid focused on Software and Information Technology. JME Venture Capital is an early-stage investment fund based in Madrid and Barcelona. The company was established in 2009 and is based in Madrid, Spain.
- Total investments:
- 131
- Last investment:
- Lead investor:
- 34%
- Fund size:
- $70M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries JME Ventures invests in
Stages JME Ventures invests in
Countries JME Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $834k–$6.3M
- Pre-Seed
- $527k–$2.5M
- Series A
- $3.5M–$18M
Investment Focus
Industry
- Software 29 (22%)
- Information Technology 17 (13%)
- Artificial Intelligence 15 (11%)
- SaaS 12 (9%)
- E-Commerce 9 (7%)
Stage
- Seed 45 (34%)
- Series A 20 (15%)
- Pre-Seed 16 (12%)
- Series B 11 (8%)
- Funding Round 11 (8%)
Country
- Spain 60 (46%)
- United States 11 (8%)
- Germany 3 (2%)
- Mexico 2 (2%)
- Italy 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ivan Landabaso
Partner
|
Partner | Total investments: 5 | Find email | |
Javier Alarco
Founding Partner & Chief Executive Officer
|
Founding Partner & Chief Executive Officer | Total investments: 3 | Find email | |
Lourdes Álvarez de Toledo
Investment Analyst and Lawyer
|
Investment Analyst and Lawyer | Total investments: 2 | Find email | |
Natalia Rojas Gonzalez
Operations Team
|
Operations Team | Total investments: 0 | Find email | |
Samuel Gil
Partner
|
Partner | Total investments: 15 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Balance is a private digital health company based in Spain that operates in the clinics and outpatient healthcare services sector. company's core mission is to provide an integrated, medical, and sustainable approach to treating obesity and overweight conditions. Moving away from traditional restrictive diets, the company leverages asubscription-based telehealth model combined with clinical pharmacology. | $3.4M / Seed / Jul 03, 2026 | ||
| Charms AI is an on‑chain mobile application focused on AI characters with persistent memory and user‑facing economies. The platform allows creators to build AI characters that can maintain long‑term conversational context and have their own wallets and tokenized assets, while users interact with, back, and trade around those characters. It sits atthe intersection of AI‑driven interaction, gaming‑style engagement, and blockchain‑based tokenization, with the overall design geared toward converting user attention and interaction into on‑chain economic flows. | $1.5M / Pre-Seed / May 14, 2026 | ||
| Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies. The company focuses on precision-engineered, custom cell culture media for cell and gene therapies and biologics. Its platforms use artificial intelligence and machine learning to map how nutrients and signals influence cells. TolemyBio supports cell therapy innovators with data-driven media design and process control. Its solutions aim to improve critical quality attributes and manufacturability for advanced therapeutic products. | $1.6M / Pre-Seed / May 12, 2026 | ||
| TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows. | $3M / Seed / Apr 29, 2026 | ||
| Incapto provides coffee solutions that combine specialty whole-bean coffee, super-automatic coffee machines, and subscription-based delivery services for consumers and businesses. The company supplies freshly roasted coffee beans sourced from multiple origins and delivers them directly to customers through recurring subscriptions, ensuringcontinuous availability and freshness. Its offering includes fully automatic coffee machines that grind and brew beans on demand, enabling users to prepare coffee without single-use capsules or manual preparation steps. The company also provides workplace coffee solutions, supplying machines, beans, and technical support for offices, hotels, and food service environments.Incapto integrates digital tools that track consumption, manage inventory, and automate replenishment, allowing customers to monitor usage and receive supplies based on demand. It also offers complementary products such as accessories, beverages, and maintenance services to support ongoing operation of its coffee systems. | $11.7M / Series B / Apr 24, 2026 | ||
| Galtea offers software that enables developers and companies to rigorously test AI agents prior to deployment. The platform automatically generates scenarios tailored to specific use cases, while applying customized metrics to pinpoint errors and evaluate performance. This helps teams thoroughly assess how their AI systems operate across diverseconditions. | $3.2M / Seed / Mar 25, 2026 | ||
| Quiver is an AI research and product company specializing in advanced models and tools for vector generation and editing. These capabilities enable high-quality, scalable creation and manipulation of vector graphics. | $8.3M / Seed / Feb 25, 2026 | ||
| Wodan AI develops artificial intelligence software focused on predictive maintenance and industrial data analysis. The company provides a platform that uses machine learning models to process sensor and operational data in order to identify patterns, detect anomalies, and anticipate equipment issues. Its technology supports data integration, modeltraining, deployment, and ongoing performance monitoring within industrial environments. Wodan AI’s solutions are used to support maintenance planning and asset management across manufacturing and other operational settings. The company applies data-driven methods to help organizations understand equipment behavior and operational risks. | $2.3M / Pre-Seed / Dec 17, 2025 | ||
| Equixely aims to help developers and organizations create more secure applications, increase their security posture, and spread knowledge of new vulnerabilities.Equixely makes available a SAAS platform that allows integrating the API security testing within the software development lifecycle (SLDC) to detect flaws, reduce bug-fixing costs andexponentially scale penetration testing upon every new functionality released.The platform can automatically perform several API attacks leveraging a novel machine learning (ML) algorithm trained over thousands of security tests. Then, Equixely returns near-real-time results and a predictive remediation plan that developers may use to fix their application issues autonomously.The Equixely advanced platform and its innovative security testing approach take an organization's API security maturity to the next level. | $11.6M / Series A / Dec 09, 2025 | ||
| Cofers es una plataforma Cloud de gestión y conciliación de la tesorería para empresas en Mexico. | $1.5M / Seed / Nov 20, 2025 | ||
| See all 131 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does JME Ventures invest in?
JME Ventures invests primarily in Software, Information Technology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 131 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is JME Ventures's check size?
JME Ventures typically joins rounds of $834k–$6.3M at Seed, $527k–$2.5M at Pre-Seed and $3.5M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds JME Ventures participates in.
How do I contact JME Ventures?
Public channels for JME Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at JME Ventures?
The team at JME Ventures includes Ivan Landabaso (Partner), Javier Alarco (Founding Partner & Chief Executive Officer) and Lourdes Álvarez de Toledo (Investment Analyst and Lawyer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
